vimarsana.com

Latest Breaking News On - Long term safety - Page 9 : vimarsana.com

EQS-News: Immunic, Inc : Immunic to Participate in Scientific and Investor Conferences in June

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in June 30.05.2023 / 12:30 CET/CEST The issuer is solely responsible

United statesRobertj foxEdna kaplanAurora hallJessica breuPaula schwartzInternational conventionNeurologic instituteExchange commissionConsortium of multiple sclerosis centersImmunic incDistribution servicesMellen centerRx communications groupInvestor conferencesMultiple sclerosis centers

Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

DEVON, Pa., May 23, 2023 Zynerba Pharmaceuticals, Inc. , the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today. | May 23, 2023

United statesMiami beachPeter vozzoZynerba pharmaceuticalsDrug administrationZynerba pharmaceuticals incAmerican society of clinical psychopharmacology annual meetingEuropean medicines agencyExchange commissionAmerican societyClinical psychopharmacology annual meetingOpen label trial assessingLong term tolerabilityTransdermal gelLong term safetySustained efficacy

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association s 2023 Annual Meeting

UZEDY significantly reduced the risk of relapse by up to 80% and prolonged the time to impending relapse by up to 5.0 times while having a similar safety profile to other formulations of. | May 20, 2023

United statesJohn kaneRichard jacksonEric hughesNational alliance on mental illnessNational pregnancy registry for atypical antipsychoticsTeva pharmaceuticalsMental health services administrationTeva neuroscience incUs national institutes of healthDepartment of psychiatryTeva pharmaceutical industries ltdAmerican psychiatric associationTeva pharmaceutical industriesRisperidone subcutaneous extended release studyMaintenance treatment

Alkermes plc: Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences

? Clinical and Patient Experience Research Delivers Insights into Treatment for People Living with Schizophrenia or Bipolar I Disorder ? DUBLIN, May 16, 2023 /PRNewswire/ Alkermes

United statesSan franciscoSandy coombsGewinn nurMarisa borgasanoAripiprazole lauroxilCraig hopkinsonAntipsychotic treatments in community telepsychiatryAmerican society of clinical psychopharmacologyAlkermes incPatients livingPatient experience research delivers insightsInternational society for bipolar disordersSchizophrenia international research societyAlkermes pharma irelandAmerican psychiatric association

Allan Domb s transparent and collaborative vision for a better Philadelphia

Domb told AL DÍA of a campaign reflective of the working community, with a long term agenda for the city, Kensington, and solving crime.

United statesMichael nutterCouncilmember allan dombDarrelll clarkeJim kenneyGreater philadelphia association of realtorsFirst day in officeA public health emergency in kensingtonFunding for recruitment of police officersCity councilCristo rey philadelphia high schoolSchool leadersCameras at every high school increase coordinationLarge philadelphia city councilmember allan dombMayor jim kenneyGreater philadelphia association

vimarsana © 2020. All Rights Reserved.